Illegal Activity
none
Blackmail
none
Date
January 3 2018
Document Type
report
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:44
Summary
This document is a financial analysis report on Valeant Pharmaceuticals as of January 3, 2018. It presents key financial data, including revenue, earnings, debt structure, and relevant financial ratios.
Metadata
- Subject
- HY Corporate Credit, HY Multi Sector.Media. Cable & Satellite
- Sender
- —
- Recipients
- —
- Document ID
- DB-SDNY-0086696
- Date
- January 3 2018
Financial Information
Amounts:9,5742,4802,2198.9648.9602.1578,7188.2324,303416395133033.838865162813373,2071,8184671561.8481.8484501.8331.4622355350179179501752.2677562.1454.4584.4584.4251.21610,6469.3209.3209.32092729.2728,8478.84729,8062314127,1412638526,09326.0932536824.91229.»125,17225.17224.41625.01125,04124.3%23.44951503mm87542$103.0342542542552246mm1.016103.M511091.048103.035903805103.0051000mm658100.4052950mm2.4291033054150mm3,81553855.685103.035.6854,6374.6374.637463751350mm1.23$1.735100.021.2351.23512351.2361.23552030mm19751.975100031,9751,97519751.975197551003mm160601.0001001.0301.00310,069,3209.3209,3209,2729.2728.8478.84751603mm1,5931030352093mm1,985193819%103.031,9881,9691.9381901,9885690689680689103.0)68925825825825852KOmm516252,2311.6132,2351.61$103.03103602.2351.61513661,6151.66616661,6151.6151.6661.6155650647617647103036476476476476475903mm89489589$98.258798958358358795550mm54354454410340540584544504S4451603mm99297399392309149939339939145330mm3,2203,2233,22393.002,9973,223122312232.99741930mm1.503,7571,75749.881,5791,7571.75747571,57953750mm3.2183,2213,22192.0)2,9633.2213.2213.7212.963121414160.4014la10141429,84627.14127.14126.38526.09326.03325.082491214.5221.6721.6721.6721.67145214.5214.525,007.9»7,5807,5807,5905.0195.0795.07934.34732,75232,75231.93632,62130.12029.28528,528
Public Knowledge
- Context
- Financial data on publicly traded companies is generally considered public knowledge, although the specific analysis and presentation in this report may not be widely known.
- Media Worthy
- Yes
Raw Analysis JSON
click to expand
Themes
Financial transactions/money flowBusiness dealings
Organizations 4
HY Corporate CreditHY Multi Sector.Media. Cable & SatelliteValeant PharmaceuticalsDeutsche Bank Securities Inc.
Text Analysis
- Tone
- Professional
- Purpose
- This document appears to be a financial analysis report on Valeant Pharmaceuticals, providing data on revenue, earnings, debt, and other financial metrics.
- Significance
- The document provides a snapshot of Valeant Pharmaceuticals' financial performance and debt structure as of January 3, 2018. It includes key financial ratios and metrics used in corporate credit analysis.
File Info
- File Name
- EFTA01385412.txt
- Dataset
- dataset_10
- Type
- Text
- Model
- gemini-2.0-flash-001
- Processed
- 2026-02-07T18:44:00.081972
- DOJ Source
- View on DOJ